Lipid Modification for the Prevention of Cardiovascular Disease (NICE Guideline)

on the 10 August 2016

Summary of NICE guidance on lipid lowering with statins.

 Download a pdf version of the above chart.

Adapted from: NICE Clinical Guideline 181 (July 2014; updated July 2016) - Lipid modification - Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease.

 

KEYWORDS: Acute coronary syndrome | Cardiovascular risk assessment | Lipid modification | Primary prevention of CVD | Secondary prevention of CVD | Statins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

The most up-to-date drug information at your fingertips.

  • Get the prescribing support you need.
  • Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Register Now
Already Registered?

Forgotten password?

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.